These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 31899333)

  • 1. Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation.
    McNeil JC; Sommer LM; Vallejo JG; Hulten KG; Kaplan SL; Flores AR
    Antimicrob Agents Chemother; 2022 Oct; 66(10):e0074522. PubMed ID: 36165630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ceftaroline in complex central nervous system infections.
    Alonso Álvarez A; Sánchez Vidal E; Ramos Merino L; Sousa Regueiro D; Serrano Areba J; Míguez Rey E; Llinares Modéjar P
    Rev Esp Quimioter; 2023 Aug; 36(4):434-435. PubMed ID: 37253231
    [No Abstract]   [Full Text] [Related]  

  • 3. A perspective on how the United States fell behind Northern Europe in the battle against methicillin-resistant Staphylococcus aureus.
    Kavanagh KT; Saman DM; Yu Y
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5789-91. PubMed ID: 24100502
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo efficacy of apramycin in murine infection models.
    Meyer M; Freihofer P; Scherman M; Teague J; Lenaerts A; Böttger EC
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6938-41. PubMed ID: 25136009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-arming ourselves against drug-resistant bacteria.
    Raherisoanjato J; Henke MT
    Cell Host Microbe; 2023 Jul; 31(7):1075-1076. PubMed ID: 37442092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence and Antimicrobial Resistance of
    Duma MN; Ciupescu LM; Dan SD; Crisan-Reget OL; Tabaran A
    Microorganisms; 2024 May; 12(5):. PubMed ID: 38792784
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic Resistance Patterns of
    Mpundu P; Muma JB; Mukubesa AN; Kainga H; Mudenda S; Bumbangi FN; Muleya W; Katemangwe P; Munyeme M
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625235
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization and Clonal Diffusion of Ceftaroline Non-Susceptible MRSA in Two Hospitals in Central Italy.
    Morroni G; Fioriti S; Salari F; Brenciani A; Brescini L; Mingoia M; Giovanetti E; Pocognoli A; Giacometti A; Molinelli E; Offidani A; Simonetti O; Cirioni O
    Antibiotics (Basel); 2021 Aug; 10(8):. PubMed ID: 34439075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of a Novel Phage for Controlling Multidrug-Resistant
    Peng Q; Fang M; Liu X; Zhang C; Liu Y; Yuan Y
    Microorganisms; 2020 Apr; 8(4):. PubMed ID: 32283667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
    Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
    J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
    Poon H; Chang MH; Fung HB
    Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of EUCAST, CLSI and USCAST ceftaroline breakpoint changes on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from US medical centres (2015-2018).
    Sader HS; Jones RN
    Clin Microbiol Infect; 2020 May; 26(5):658-659. PubMed ID: 31899333
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
    Urbán E; Stone GG
    Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.
    Stryjewski ME; Jones RN; Corey GR
    Diagn Microbiol Infect Dis; 2015 Mar; 81(3):183-8. PubMed ID: 25583130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
    Khan A; Rivas LM; Spencer M; Martinez R; Lam M; Rojas P; Porte L; Silva F; Braun S; Valdivieso F; Mv Lhauser M; Lafourcade M; Miller WR; García P; Arias CA; Munita JM
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315958
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.